140 related articles for article (PubMed ID: 31982886)
1. Characterizing Health Outcomes in Idiopathic Pulmonary Fibrosis using US Health Claims Data.
Mortimer KM; Bartels DB; Hartmann N; Capapey J; Yang J; Gately R; Enger C
Respiration; 2020; 99(2):108-118. PubMed ID: 31982886
[TBL] [Abstract][Full Text] [Related]
2. Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in England from 2008 to 2018: a cohort study.
Gupta R; Morgan AD; George PM; Quint JK
Thorax; 2024 Jun; 79(7):624-631. PubMed ID: 38688708
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of Idiopathic Pulmonary Fibrosis in Northern Italy.
Harari S; Madotto F; Caminati A; Conti S; Cesana G
PLoS One; 2016; 11(2):e0147072. PubMed ID: 26841042
[TBL] [Abstract][Full Text] [Related]
4. Examining prevalence and predictors of pulmonary hypertension in adults with idiopathic pulmonary fibrosis: a population-based analysis in the United States.
Desai R; Katukuri N; Kanagala SG; Ghadge N; James A; Tajdin B; Nalla A; Vutukuru SD; Kotharu DM; Kadiyala A; Vyas A; Prajjwal P; Ogbu I
J Med Life; 2024 Jan; 17(1):35-40. PubMed ID: 38737661
[TBL] [Abstract][Full Text] [Related]
5. Unravelling the health and economic burden of interstitial lung diseases in adults in Australia.
Cox IA; de Graaff B; Zheng Q; Corte TJ; Haydn Walters E; Palmer AJ
Aust J Gen Pract; 2024 May; 53(5):333-336. PubMed ID: 38697068
[TBL] [Abstract][Full Text] [Related]
6. A multidimensional classifier to support lung transplant referral in patients with pulmonary fibrosis.
Pugashetti JV; Kim JS; Combs MP; Ma SF; Adegunsoye A; Linderholm AL; Strek ME; Chen CH; Dilling DF; Whelan TPM; Flaherty KR; Martinez FJ; Noth I; Oldham JM
J Heart Lung Transplant; 2024 Jul; 43(7):1174-1182. PubMed ID: 38556070
[TBL] [Abstract][Full Text] [Related]
7. A Step towards understanding coronary artery disease: a complication in idiopathic pulmonary fibrosis.
Sinha R; Nanavaty D; Azhar A; Devarakonda P; Singh S; Garikipati R; Sanghvi A; Manoharan S; Parhar G; Zaman K; Ayala-Rodriguez C; Vasudevan V; Reddy S; Gerolemou L
BMJ Open Respir Res; 2024 Mar; 11(1):. PubMed ID: 38508700
[TBL] [Abstract][Full Text] [Related]
8. Smoking status and clinical outcome in idiopathic pulmonary fibrosis: a nationwide study.
Yoon HY; Kim H; Bae Y; Song JW
Respir Res; 2024 Apr; 25(1):191. PubMed ID: 38685071
[TBL] [Abstract][Full Text] [Related]
9. The preventative effects of statin on lung cancer development in patients with idiopathic pulmonary fibrosis using the National Health Insurance Service Database in Korea.
Lee YJ; Kang N; Nam J; Lee EG; Ryoo J; Kwon SS; Kim YH; Kang HS
PLoS One; 2024; 19(3):e0299484. PubMed ID: 38478558
[TBL] [Abstract][Full Text] [Related]
10. Japanese guidelines for the treatment of idiopathic pulmonary fibrosis 2023:Revised edition.
Bando M; Homma S; Date H; Kishi K; Yamauchi H; Sakamoto S; Miyamoto A; Goto Y; Nakayama T; Azuma A; Kondoh Y; Johkoh T; Nishioka Y; Fukuoka J; Miyazaki Y; Yoshino I; Suda T;
Respir Investig; 2024 May; 62(3):402-418. PubMed ID: 38484504
[TBL] [Abstract][Full Text] [Related]
11. [Not Available].
Hoyer N; Bendstrup E; Davidsen JR; Lund TK; Shaker SB
Ugeskr Laeger; 2023 Aug; 185(33):. PubMed ID: 37615152
[TBL] [Abstract][Full Text] [Related]
12. Association between statin use and the risk for idiopathic pulmonary fibrosis and its prognosis: a nationwide, population-based study.
Park J; Lee CH; Han K; Choi SM
Sci Rep; 2024 Apr; 14(1):7805. PubMed ID: 38565856
[TBL] [Abstract][Full Text] [Related]
13. Association between Antacid Exposure and Risk of Interstitial Lung Diseases.
Bae S; Loloci G; Lee DY; Jang HJ; Jeong J; Choi WI
Tuberc Respir Dis (Seoul); 2024 Apr; 87(2):185-193. PubMed ID: 38111098
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic pulmonary fibrosis--a systematic review on methodology for the collection of epidemiological data.
Kaunisto J; Salomaa ER; Hodgson U; Kaarteenaho R; Myllärniemi M
BMC Pulm Med; 2013 Aug; 13():53. PubMed ID: 23962167
[TBL] [Abstract][Full Text] [Related]
15. Understanding the lived experience of idiopathic pulmonary fibrosis and how this shapes views on home-based pulmonary rehabilitation in Delhi, India.
Hanif H; Ahmed O; Manifield J; Ishrat R; Pina I; Ahmed Z; Shibli M; Malcolm D; Talwar D; Singh SJ; Orme MW
Chron Respir Dis; 2024; 21():14799731241258216. PubMed ID: 38787595
[TBL] [Abstract][Full Text] [Related]
16. Patients' experiences of coping with Idiopathic Pulmonary Fibrosis and their recommendations for its clinical management.
Senanayake S; Harrison K; Lewis M; McNarry M; Hudson J
PLoS One; 2018; 13(5):e0197660. PubMed ID: 29791487
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis, current treatments and future directions for idiopathic pulmonary fibrosis.
Loomis-King H; Flaherty KR; Moore BB
Curr Opin Pharmacol; 2013 Jun; 13(3):377-85. PubMed ID: 23602652
[TBL] [Abstract][Full Text] [Related]
18. Hospital-level variation in practices and outcomes for patients with severe acute exacerbations of idiopathic pulmonary fibrosis: a retrospective multicentre cohort study.
Shankar DA; Walkey AJ; Hawkins FJ; Bosch NA; Peterson D; Law AC
BMJ Open Respir Res; 2023 Apr; 10(1):. PubMed ID: 37076251
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Chronic Comorbidities on Outcomes in Acute Exacerbations of Idiopathic Pulmonary Fibrosis.
Baig SH; Yoo EJ
Life (Basel); 2024 Jan; 14(1):. PubMed ID: 38276285
[TBL] [Abstract][Full Text] [Related]
20. The need for patient-centred clinical research in idiopathic pulmonary fibrosis.
Russell AM; Sprangers MA; Wibberley S; Snell N; Rose DM; Swigris JJ
BMC Med; 2015 Sep; 13():240. PubMed ID: 26399318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
